European firm eyes BioSante's nanoparticle technology
BioSante Pharmaceuticals has licensed its calcium phosphate (CaP) nanotechnology - used for drug delivery and as an adjuvant for vaccines - to an unnamed European pharmaceutical company.
Archives for September 14, 2005
Sandoz takes issue with FDA over biogenerics
Sandoz, the generic drug unit of Swiss pharmaceutical group Novartis, has filed a law suit against the US Food and Drug Administration (FDA) alleging that the agency is dragging its feet in a review of a 'biogeneric' drug filed by the company.
Merck and EFSD to advance novel diabetes research
Merck Sharp & Dohme (MSD), the UK subsidiary of Merck & Co of the US, is to partner with the European Foundation for the Study of Diabetes (EFSD), to further explore a novel area of diabetes research.
Report sees boom time ahead for biopharma CMOs
Pharmaceutical companies are increasingly looking to retain their internal focus on research and development (R&D) and marketing while outsourcing their manufacturing processes, thus fueling a growing demand for the manufacturing capacities of...
Merck signs unique drug development deal
Merck has signed a research and drug development agreement with FoxHollow Technologies, which represents the first pharmaceutical-medical device partnership aimed at identifying cardiovascular biomarkers for use as diagnostics and as tools for drug...
Stanelco develops alternative to gelatine hardshells
UK-based Stanelco says it has developed a starch-based alternative to gelatine hardshell capsules that could also offer cost benefits for dietary supplement makers.
DrugResearcher.com's publisher to be branded as Decision News Media
Novis, the publisher of DrugResearcher.com, 22 other business news websites and more than 50 specialist e-newsletters, is today changing its name to Decision News Media, to convey the editorial ethos that has made the group's news services into market...
Joint project produces unique bacterial diagnosis application
STMicroelectronics and Mobidiag unveil a new technology that enables rapid bacterial diagnosis. The new lab-on-a-chip application allows a more accurate detection of infectious diseases that will lead to better treatment choices.